riskScore® Validation

March 25, 2021

The recent publication in JCO Precision Oncology demonstrates the value of a combined risk score that incorporates polygenic risk and clinical variables for pre...

Continue Reading

Cost of Myriad myRisk Testing

August 10, 2020

Cost should never be a barrier when patients need genetic testing. That’s why it’s Myriad’s promise to make testing accessible and affordable. For pati...

Continue Reading

Variant Reclassification

July 20, 2020

Why is Variant Reclassification in Hereditary Cancer Testing Important? Variant classification is a key component of germline testing, allowing patients to hav...

Continue Reading

An Overview of riskScore

June 9, 2020

Myriad’s myRisk Hereditary Cancer test includes analysis of several well-known breast cancer genes. However, 10% or fewer of breast cancers in women are hered...

Continue Reading

Myriad Corporate Statement

June 9, 2020

We are heartbroken over the systemic discrimination and racism that have persisted in this nation for too long. We have been quiet in reflection but believe tha...

Continue Reading

MomGenes: Knowledge is Power

May 5, 2020

Every Mother’s Day, we stop and take a moment to thank our mothers for their love and support. We discuss characteristics and mannerisms we inherited from t...

Continue Reading